vasomotor


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to vasomotor: vasomotor rhinitis, secretomotor

va·so·mo·tor

(vā′zō-mō′tər)
adj.
Relating to, causing, or regulating constriction or dilation of blood vessels.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

vasomotor

(ˌveɪzəʊˈməʊtə)
adj
1. (Pharmacology) (of a drug, agent, nerve, etc) relating to or affecting the diameter of blood vessels
2. (Physiology) (of a drug, agent, nerve, etc) relating to or affecting the diameter of blood vessels
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

vas•o•mo•tor

(ˌvæs oʊˈmoʊ tər, ˌveɪ zoʊ-)

adj.
regulating the diameter of blood vessels, as certain nerves.
[1860–65]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj. 1. vasomotor - relating to the nerves and muscles that cause the blood vessels to constrict or dilate
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

va·so·mo·tor

n. vasomotora, agente que regula las contracciones y la dilatación de los vasos sanguíneos;
a. vasomotor-a, que causa dilatación o contracción en los vasos sanguíneos;
___ angina → angina ___;
centro ___ → ___ centro;
___ epilepsy → epilepsia;
___ rhinitis → rinitis ___;
___ spasm → espasmo ___;
___ stimulant → estimulante cardíaco;
___ system → ___ vasomotor.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
ENPNewswire-August 7, 2019--Astellas Initiates Phase 3 Clinical Trials for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms
Astellas Initiates Phase 3 Clinical Trials for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms
Japanese healthcare company Astellas Pharma Inc (TSE:4503) on Tuesday commenced the treatment of the first patient under the Phase 3 pivotal SKYLIGHT 1 trial for fezolinetant for the treatment of moderate-to-severe vasomotor symptoms (VMS) including hot flashes and night sweats associated with menopause.
Astellas begins Phase 3 clinical trials of fezolinetant in postmenopausal women across US, Canada and Europe
Among 18 women with vasomotor symptoms, 6 (33%) preferred nonhormone treatment, 7 (39%) preferred hormone treatment, and 5 (28%) were unsure; among 18 with genitourinary symptoms of menopause, 6 (33%) preferred nonprescription treatment, 7 (39%) preferred topical hormone therapy, and 5 (28%) were unsure, Dr.
Online counseling clarifies options for menopausal women
BIJUVA is an FDA-approved, bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus.
TherapeuticsMD to present BIJUVA, ANNOVERA data at ACOG 2019
Bijuva is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral daily capsule for the treatment of moderate-to-severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.
TherapeuticsMD Launches Bijuva Hormone Therapy in the US
Once-daily dosing also significantly dropped the frequency of moderate to severe vasomotor symptoms by 2.1-2.6 events daily, compared with placebo at the end of 12 weeks.
Fezolinetant looks good for hot flashes in phase 2B trial
BIJUVA[TM] has been US Food and Drug Administration (FDA)-approved as the first oral treatment for moderate-to-severe vasomotor symptoms due to menopause in women with a uterus.
TREATMENT FOR VASOMOTOR SYMPTOMS
* Soy: modestly helpful for vasomotor symptoms; (Associated with modest effects on bone density and lipid lowering.)
Sample Treatment Strategies in Women's Health
In this study, we planned to research the correlation between the severity of climacteric symptoms, led by vasomotor symptoms, in the menopausal transition period and postmenopausal period and the correlation of severity of symptoms with the T/ D balance.
The Relationship between Climacteric Symptoms and Thiol/Disulphide Homeostasis
Hormone therapy remains the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture.
Time to take the fear out of hormone therapy
When asked whether they experienced any symptoms commonly associated with menopause, such as hot flashes and night sweats (vasomotor symptoms), a significant percentage reported having them well into their 60s, 70s and 80s.
Hot flashes can last longer than you think

Full browser ?